BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 11653222)

  • 21. Questions and answers.
    Goodwin FK
    J Calif Alliance Ment Ill; 1994; 5(1):45-7. PubMed ID: 11653321
    [No Abstract]   [Full Text] [Related]  

  • 22. Fears mount for gene scrutiny as watchdog faces axe.
    Kiernan V
    New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540
    [No Abstract]   [Full Text] [Related]  

  • 23. OPRR and FDA propose revised expedited review categories.
    McGough H
    IRB; 1998; 20(1):9, 11. PubMed ID: 11655326
    [No Abstract]   [Full Text] [Related]  

  • 24. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract]   [Full Text] [Related]  

  • 25. Medicine, animal experimentation, and the moral problem of unfortunate humans.
    Frey RG
    Soc Philos Policy; 1996; 13(2):181-211. PubMed ID: 11653298
    [No Abstract]   [Full Text] [Related]  

  • 26. The FDA's final regulations: IRBs and medical devices.
    Holder AR
    IRB; 1980; 2(6):1-4. PubMed ID: 11661803
    [No Abstract]   [Full Text] [Related]  

  • 27. Xenotransplantation: benefits, risks and regulation.
    Cooper DK
    Ann R Coll Surg Engl; 1996 Mar; 78(2):92-6. PubMed ID: 8678465
    [No Abstract]   [Full Text] [Related]  

  • 28. Annual review: observed deficiencies and suggested corrections.
    Adams MS; Conrad DA
    IRB; 1996; 18(6):1-4. PubMed ID: 11654743
    [No Abstract]   [Full Text] [Related]  

  • 29. NIH approves the consent for Baby Fae, or does it?
    Levine C
    Hastings Cent Rep; 1985 Apr; 15(2):2. PubMed ID: 11643771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IRBs and research with human biological materials.
    Maloney DM
    Hum Res Rep; 1999 Jan; 14(1):2. PubMed ID: 11657556
    [No Abstract]   [Full Text] [Related]  

  • 31. Animals as organ donors? Not until they're germ-free.
    Stolberg SG
    N Y Times Web; 1998 Feb; ():F1, F6. PubMed ID: 11647603
    [No Abstract]   [Full Text] [Related]  

  • 32. Getting new drugs to people with AIDS: a public policy response to Lansdale.
    Cohen MN
    Hastings Constit Law Q; 1991; 18(3):471-85. PubMed ID: 11651493
    [No Abstract]   [Full Text] [Related]  

  • 33. Institutional review boards and public health research: an analysis.
    Hogue LL
    Univ Ark Little Rock Law J; 1978; 1(2):428-54. PubMed ID: 11661619
    [No Abstract]   [Full Text] [Related]  

  • 34. Fetal research II: the ethical questions.
    Brown HO
    Hum Life Rev; 1975; 1(4):118-28. PubMed ID: 11663565
    [No Abstract]   [Full Text] [Related]  

  • 35. "Evaluation of human subject protections in schizophrenia research conducted by the University of ..." (Part III).
    Maloney DM
    Hum Res Rep; 2000 Jan; 15(1):5-6. PubMed ID: 11658036
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of clinical research: who's protecting who from what?
    Petricciani JC
    Food Drug Cosmet Law J; 1979 Apr; 34(4):205-7. PubMed ID: 11661718
    [No Abstract]   [Full Text] [Related]  

  • 37. Human experimentation: the review process in practice.
    Cowan DH
    Case West Reserve Law Rev; 1975; 25(3):533-64. PubMed ID: 11661165
    [No Abstract]   [Full Text] [Related]  

  • 38. Proposed requirements for informed consent go beyond current federal regulations.
    Hum Res Rep; 1994 Jul; 9(7):1-3. PubMed ID: 11659879
    [No Abstract]   [Full Text] [Related]  

  • 39. Commission says institutional review boards should change procedures now.
    Maloney DM
    Hum Res Rep; 1999 Jan; 14(1):1-2. PubMed ID: 11657555
    [No Abstract]   [Full Text] [Related]  

  • 40. The federal fetal experimentation regulations: an establishment clause analysis.
    Friedman JM
    Minn Law Rev; 1977 Jun; 61(6):961-1005. PubMed ID: 11664831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.